Download Optimal DX's White Paper on COVID-19. With over 200 cited references, this paper is a deep dive into the co-morbidities associated with an adverse outcome of a COVID-19 infection and how we can use blood biomarkers and biomarker patterns to you with insight into the severity of metabolic dysfunction caused by the virus and the body’s immune response to it.
These patterns can be used to help predict the need for intensive care and evaluate the risk of morbidity and mortality. They can also help provide guidance for targeted nutrition support and intervention. A functional blood chemistry analysis helps identify biomarkers outside the optimal range as well as patterns that assist in creating a comprehensive assessment of COVID-19 and its severity.
